ClinConnect ClinConnect Logo
Search / Trial NCT06800170

Treatment of Menstrual Cycle Alterations in Adolescents

Launched by LO.LI.PHARMA S.R.L · Jan 24, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Myo Inositol Dioscorea Villosa Adolescents

ClinConnect Summary

This clinical trial is looking at how two natural treatments, Myo-Inositol and Dioscorea Villosa, can help improve irregular menstrual cycles in adolescent girls, especially those who have conditions like Polycystic Ovary Syndrome (PCOS) or experience infrequent periods (known as oligomenorrhea) or no periods at all (known as amenorrhea). The goal is to see if these treatments can help restore more regular menstrual cycles for young women aged 14 to 19 who have already started their periods for at least three years.

To participate in the study, girls must be within that age range and experiencing either infrequent periods or no periods. However, those who have never had a period, have certain hormonal disorders, or are currently taking specific medications or supplements related to menstrual health are not eligible. If you join the study, you can expect to be part of a program that evaluates how these treatments might improve your menstrual cycle, contributing to a better understanding of menstrual health in young women. The study is not yet recruiting participants, so you would need to wait for it to start.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • adolescent women aged 14-19 years old, with at least 3 years passed after menarche, and oligomenorrhea or amenorrhea
  • Exclusion Criteria:
  • Primary amenorrhea.
  • Hyperandrogenism due to other factors (i.e. adrenal hyperplasia or Cushing syndrome).
  • Hyperprolactinemia or overt hypothyroidism (TSH ≥4).
  • Other hormonal alterations.
  • Ongoing hormonal therapies, including OCPs, six months before enrollment.
  • Ongoing pharmacological therapies.
  • Ongoing use of myo-Inositol supplement or other source of myo-Inositol, or Dioscorea villosa, six months before enrollment.

About Lo.Li.Pharma S.R.L

lo.li.pharma s.r.l. is a leading pharmaceutical company dedicated to the development and commercialization of innovative therapies aimed at improving patient outcomes across various therapeutic areas. With a strong commitment to research and development, lo.li.pharma s.r.l. leverages cutting-edge science and technology to advance clinical trials that address unmet medical needs. The company prides itself on its rigorous quality standards and collaborative approach, working closely with healthcare professionals, regulatory bodies, and research institutions to bring safe and effective treatments to market. Through its strategic initiatives, lo.li.pharma s.r.l. strives to enhance the well-being of patients worldwide while fostering sustainable growth in the pharmaceutical industry.

Locations

Rome, , Italy

Tbilisi, , Georgia

Saint Petersburg, , Russian Federation

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported